Article
Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma.
Genome medicine - 14 Jul 2021
Meiller Clément, Montagne François, Hirsch Theo Z, Caruso Stefano, de Wolf Julien, Bayard Quentin, Assié Jean-Baptiste, Meunier Léa, Blum Yuna, Quetel Lisa, Gibault Laure, Pintilie Ecaterina, Badoual Cécile, Humez Sarah, Galateau-Sallé Françoise, Copin Marie-Christine, Letouzé Eric, Scherpereel Arnaud, Zucman-Rossi Jessica, Le Pimpec-Barthes Françoise, Jaurand Marie-Claude, Jean Didier
Abstract excerpt
BACKGROUND: Malignant pleural mesothelioma (MPM) is a heterogeneous cancer. Better knowledge of molecular and cellular intra-tumor heterogeneity throughout the thoracic cavity is required to develop efficient therapies. This study focuses on molecular intra-tumor heterogeneity using the largest series to date in MPM and is the first to report on the multi-omics profiling of a substantial series of multi-site...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
